Grants power two decades of statewide impact
The university’s medical school would not be the UW School of Medicine and Public Health without the Wisconsin Partnership Program (WPP), celebrating its 20th anniversary this year.
Noninvasive ventilation better for patients
Recently published results from a clinical trial showed that for critically ill adults needing tracheal intubation for emergency airway support, the method health care providers choose to use for providing supplemental oxygen before the intubation procedure affects the patient’s risk of hypoxemia, or potentially life-threatening low levels of blood oxygen.
Humid heat impacts dialysis patients
A large, population-based study shows that people receiving regular dialysis to treat kidney disease are vulnerable during heat waves, especially those living in cities in the humid southeastern states, resulting in higher death rates.
When doctors sit, patients feel better
A new study indicates that the simple act of a doctor sitting in a chair during hospital bedside discussions improved the experience for physicians and patients alike.
Gut inflammation linked to aging and Alzheimer’s disease
A new study by researchers at the University of Wisconsin School of Medicine and Public Health suggests a link between gut inflammation and changes in the brain and declines in memory, further supporting a connection between the gut and brain in Alzheimer’s disease.
UW–Madison receives $150 million grant to lead nationwide Alzheimer’s disease study
The University of Wisconsin School of Medicine and Public Health has been awarded funding from the National Institutes of Health for a nationwide research initiative to investigate the neurobiology of Alzheimer’s disease and related dementias.
New UW study examines COVID-19 vaccines in people with weakened immune systems
Researchers at the University of Wisconsin School of Medicine and Public Health are exploring the ideal vaccine booster strategy for immunosuppressed patients to protect those at higher risk of severe illness and complications from COVID-19 infection.
UW study links past military service to Alzheimer’s disease
The brains of deceased military veterans had higher levels of two abnormal proteins considered hallmarks of Alzheimer’s disease, suggesting that military veterans face a greater risk for developing Alzheimer’s, according to a new study from the University of Wisconsin School of Medicine and Public Health.
UW study examines potential treatment for Alzheimer’s disease
Researchers at the University of Wisconsin School of Medicine and Public Health are investigating whether the drug leuprolide, which is approved for prostate cancer in men, can be used to treat symptoms of Alzheimer’s disease in women.
UW study seeks IBD patients to study effectiveness of updated COVID-19 vaccines
Researchers at the University of Wisconsin School of Medicine and Public Health are investigating how well the updated monovalent COVID-19 vaccines work for inflammatory bowel disease patients.
Study explores midlife factors associated with blood biomarkers of neurodegeneration and Alzheimer’s disease
Lifestyle and chronic health conditions in middle age, along with a person’s education level, show associations with emerging blood markers of neurodegeneration and Alzheimer’s disease, according to a new study by researchers at the University of Wisconsin School of Medicine and Public Health.
Clinical trial for severe dry mouth treatment launching soon at UW
The UW Health | Carbone Cancer Center and UW Program for Advanced Cell Therapy, or PACT, will soon begin a clinical trial using a recently developed cell therapy to treat severe dry mouth, which is a significant symptom of graft-versus-host disease and Sjögren’s disease.